PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A309. A total of 38 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $72,598 | -18.9% | 43,734 | -2.3% | 0.00% | – |
| Q2 2023 | $89,520 | – | 44,760 | +11231.6% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 395 | -65.0% | 0.00% | – |
| Q1 2022 | $1,000 | -87.5% | 1,127 | -80.7% | 0.00% | – |
| Q3 2021 | $8,000 | +33.3% | 5,847 | +352.2% | 0.00% | – |
| Q1 2021 | $6,000 | -25.0% | 1,293 | -38.4% | 0.00% | – |
| Q4 2020 | $8,000 | 0.0% | 2,100 | 0.0% | 0.00% | – |
| Q3 2020 | $8,000 | – | 2,100 | +2000.0% | 0.00% | – |
| Q2 2020 | $0 | – | 100 | 0.0% | 0.00% | – |
| Q4 2019 | $0 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 2,470,332 | $8,967,000 | 6.83% |
| Psagot Value Holdings Ltd. | 470,255 | $1,707,000 | 0.04% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 212,591 | $772,000 | 0.02% |
| UBS OCONNOR LLC | 150,000 | $544,000,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 10,042 | $36,000 | 0.01% |
| Renaissance Technologies | 488,634 | $1,774,000 | 0.00% |
| Squarepoint Ops LLC | 22,068 | $80,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 222 | $1,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 50,280 | $183,000 | 0.00% |